L. Balbiani

发表

Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancer.

L. Fein, D. Lewi, S. Jovtis, 2001, Seminars in oncology.

Phase II of doxorubicin/taxol in metastatic breast cancer

E. Cazap, D. Lewi, A. Álvarez, 1999, Breast Cancer Research and Treatment.

Gemcitabine plus Paclitaxel as First-Line Chemotherapy for Patients with Advanced Breast Cancer

E. Mickiewicz, L. Balbiani, A. Z. Comba, 2004, Oncology.

Phase II trial of gemcitabine (GEM), 5-Fluoruracil (5-FU) and leucovorin (LV) in advanced pancreatic cancer (PC)

L. Fein, D. Lewi, S. Jovtis, 1999 .

Final results of a phase II trial of first-time therapy with gemcitabine (Gemtro®) (G) and carboplatin (C) in patients (pts) with advanced non-small cell lung cancer (NSCLC)

M. Orlando, S. Jovtis, G. Témperley, 2000 .

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5‐fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma

L. Fein, J. Block, R. Chacón, 1999, Cancer.

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients.

M. Vilanova, E. Cazap, G. Recondo, 2001, European journal of cancer.

Treatment of Non-Small Cell Lung Cancer with Ifosfamide (IFO) + 4’-Epiadriamycin (EPI) + Platinum vs. IFO + EPI: A GETLAC Study

G. Témperley, C. E. Araújo, L. Balbiani, 1995 .